China's pharmaceutical industry is in a stage of rapid growth. At present, the proportion of total health expenses is still at a low level of GDP.
It is less than 5%. Compared to developed country the United States (17%), there is a considerable gap. But in recent years it continues to rise. Pharmaceutical irinotecan industry that is overall in a rising channel will inevitably bring about the boom of anti-cancer drugs in this market segment. Anti-cancer drug’s sales volume increasing year by year is also increasingly becoming an indispensable force for driving rapid growth of the pharmaceutical industry.
Aging and urbanization to promote the increased demand for anti-cancer drugs. The past 30 years, cancer mortality increased by 80%, the annual cancer incidence of about 2.6 million, the death toll of about 1.8 million. Lead to cancer, the incidence of rising main reason is that the living environment, changes in the way and the increasing pressure on the survival of various objective factors. Among them, the aging and urbanization are the two most important factors.
The anti-cancer drug patent expires, generic drug import substitution welcome opportunity. Global drug development is difficult, have turned to generic drugs, the generics market capacity will expand rapidly. In the face of China's huge market, import substitution of generic drugs will usher in new opportunities.
The chemotherapy drug market developed, targeted drug market is growing rapidly. Throughout the chemotherapy market has matured and grew steadily. This commonly used drugs, paclitaxel and docetaxel for the clinical treatment of cancer, both accounting for 21% of the market share of the Chinese anti-cancer drug products in 2009. Targeted therapies are the vital force of the rapid rise in recent years, anti-cancer drugs. By 2015, the global targeted therapies market size is expected to more than 50 billion U.S. dollars, up to 11% compound annual growth rate, and the area will have more than eight new drugs to market leading products.
Strong R & D powder and rich reserves of new drugs are the core strengths of the industry leader. The global anti-cancer drugs giants all have a strong drug research and development team. The annual R & D input is 15% -20% of total revenue. Chinese anti-cancer drugs leader’s R & D spending is about 8%. Comparing with the giants in the world, there is still a gap. But it is much higher than the average of 2 percent of China's pharmaceutical and biotech industry. That fully shows that the anticancer drug sub-sectors is relatively high-end pharmaceutical field. It is also a concrete manifestation of the industrial high barriers. Production enterprise business strategy can not ignore the new drug development, production and reserve continuity because of the long cycle and high-risk for drug development.
Source:http://www.cospcn.com
The application of tungsten in various industries
Steel Industry Most of tungsten applied in the production of special steels. The widely used high-speed steel was containing 9-24% of tungsten, 3.8-4.6% of chromium, 1-5% of vanadium, 4-7% of cobalt, 0.7-1.5% of carbon.
Magic effects of coconut oil
According to records, coconut oil can be regarded as the nobility of skin care plant extracts. It was rich in exotic tension of tropical plants, which can enhance the contractile force of the pores, perfectly beautify and nourish the skin.
The Evolution and Impact of Abamectin and Emamectin Benzoate in Pest Control
Abamectin and its derivative, emamectin benzoate, have emerged as pivotal substances in the realm of pest control, offering a broad-spectrum efficacy against various pests while maintaining a favorable environmental profile. As the agricultural industry continues to evolve, these compounds have adapted to meet the growing challenges of pest resistance, expanding their market applications and maintaining cost-effectiveness despite rising production costs.
